ABOUT US

Obesity is a major health concern across the globe. The obesity pandemic is expected to continue increasing over the forecastafter the COVID 19 pandemic, after COVID 19 pandemic the obesity rate increased . thus fueling the market growth. for instance, according to the World Health Organization 2016 data, around 1.5 billion individuals were overweight, and out of which around 650 million were obese. In addition, it is estimated that, after COVID 19 pandemic, 2.8 billion individuals will be over weight and more than 1.8 billion will be obese especially. The American Society for Metabolic and Bariatric Surgery (ASMBS) included the intragastric balloon in the list of procedures and devices approved by the society as a treatment option. The ASMBS is anticipated to increase the adoption of intragastric balloons as one of the most save and effective weight loss procedure.

Also the high costs and procedural complications associated with bariatric surgery procedures is anticipated to increase the demand for intragastric balloons. Furthermore, the development of intragastric Balloon makes it one of the most effective, most save and in the same time most cheap weight loss procedure, which reducing the need for complex insertion tools and the likelihood of Bariatric surgery such as (Gastric bypass, gastric sleeve .. etc ) adverse effects.